Restless Legs Syndrome
|
0.190 |
Biomarker
|
disease |
BEFREE |
Restless legs syndrome (RLS) is considered a genetic disease and, following a genome-wide association study conducted in 2007, the mitogen-activated protein kinase 5 (MAP2K5) gene has been regarded as the promising candidate gene for RLS.
|
29422930 |
2018 |
Restless Legs Syndrome
|
0.190 |
Biomarker
|
disease |
BEFREE |
Our findings directly link MEIS1 and SKOR1, two significantly associated genes with RLS and also prioritize SKOR1 over MAP2K5 in the RLS associated intergenic region of MAP2K5/SKOR1 found by GWAS.
|
30111810 |
2018 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
GWASCAT |
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis.
|
29029846 |
2017 |
Restless Legs Syndrome
|
0.190 |
Biomarker
|
disease |
BEFREE |
Our results confirmed the association of BTBD9 and MAP2K5/SKOR1 with primary RLS in Chinese population.
|
28329290 |
2017 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
BEFREE |
A predicted miR-330-3p target site SNP (rs41305272) in mitogen-activated protein kinase kinase 5 (MAP2K5) mRNA was in LD (d' = 1.0, r(2) = 0.02) with a reported GWAS-identified variant for restless legs syndrome (RLS), a disorder frequently comorbid with anxiety and depression, possibly because of a shared pathophysiology.
|
24436253 |
2014 |
Restless Legs Syndrome
|
0.190 |
Biomarker
|
disease |
BEFREE |
Variants in MEIS1, BTBD9, and MAP2K5/SKOR1 confer a significant risk of RLS in a US population.
|
21925394 |
2011 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
BEFREE |
In the German sample, variants in MEIS1 and BTBD9 were associated with RLS in ESRD (P(nom)≤0.004, ORs 1.52 and 1.55), whereas, in the Greek sample, there was a trend for association to MAP2K5/SKOR1 and BTBD9 (P(nom)≤0.08, ORs 1.41 and 1.33).
|
21572129 |
2011 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.
|
21779176 |
2011 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.
|
21779176 |
2011 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
BEFREE |
Restless legs syndrome (RLS) is associated with common variants in three intronic and intergenic regions in MEIS1, BTBD9, and MAP2K5/LBXCOR1 on chromosomes 2p, 6p and 15q.
|
19279021 |
2009 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.
|
17637780 |
2007 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
BEFREE |
In a genome-wide association study we found highly significant associations between RLS and intronic variants in the homeobox gene MEIS1, the BTBD9 gene encoding a BTB(POZ) domain as well as variants in a third locus containing the genes encoding mitogen-activated protein kinase MAP2K5 and the transcription factor LBXCOR1 on chromosomes 2p, 6p and 15q, respectively.
|
17637780 |
2007 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
BEFREE |
Genetic risk variants for RLS have recently been identified in two genes, one of them the homeobox gene MEIS1, known to be involved in embryonic development and variants in a second locus containing the genes encoding mitogen-activated protein kinase MAP2K5, and the transcription factor LBXCOR1.
|
18081164 |
2007 |
Restless Legs Syndrome
|
0.190 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.
|
17637780 |
2007 |